Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Blueprint Medicines Corp.
Sponsor

Blueprint Medicines Corp.

United States 45 Sidney Street, 02139-4133, United States

About the sponsor

Blueprint Medicines Corp. is active in advanced systemic mastocytosis, indolent systemic mastocytosis, and related KIT-altered blood cancers, with research also extending to SM-AHN and other mast cell disorders.

  • Advanced systemic mastocytosis
  • Indolent systemic mastocytosis
  • KIT-altered hematologic malignancies
  • SM-AHN

Its clinical portfolio in this area includes therapies aimed at controlling mast cell disease activity and addressing symptom burden in both adult and pediatric settings.

About Specializations

Blueprint Medicines Corp. runs clinical trials in conditions such as Systemic mastocytosis, Indolent systemic mastocytosis, Neoplasm malignant, Urticaria chronic, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

8 clinical trials

Systemic mastocytosis

Recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Avapritinib
  • Sponsor:Blueprint Medicines Corp.

Indolent systemic mastocytosis

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Elenestinib Phosphate
  • Sponsor:Blueprint Medicines Corp.

Neoplasm malignant

Not yet recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Blu-451
  • Sponsor:Blueprint Medicines Corp.

Urticaria chronic

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Blueprint Medicines Corp.

Systemic mastocytosis

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Blueprint Medicines Corp.

Neoplasm

Not recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Avapritinib
  • Sponsor:Blueprint Medicines Corp.

Neoplasm malignant

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Blu-222
  • Sponsor:Blueprint Medicines Corp.

Systemic mastocytosis+1

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Avapritinib
  • Sponsor:Blueprint Medicines Corp.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.